Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 11, Number 6, 1 June 2013

Free Content June Editorial
pp. 1005-1005(1)
Authors: Rosendaal, F. R.; Reitsma, P. H.

Favourites:
ADD

Free Content Inherited thrombocytopenias frequently diagnosed in adults
pp. 1006-1019(14)
Authors: Balduini, C. L.; Savoia, A.; Seri, M.

Favourites:
ADD

Free Content Antithrombin is protective against myocardial ischemia and reperfusion injury
pp. 1020-1028(9)
Authors: Wang, J.; Wang, Y.; Wang, J.; Gao, J.; Tong, C.; Manithody, C.; Li, J.; Rezaie, A. R.

Favourites:
ADD
Favourites:
ADD

Free Content Cost‐effectiveness of additional catheter‐directed thrombolysis for deep vein thrombosis
pp. 1032-1042(11)
Authors: Enden, T.; Resch, S.; White, C.; Wik, H. S.; Kløw, N. E.; Sandset, P. M.

Favourites:
ADD

Free Content Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels
pp. 1043-1052(10)
Authors: Dargaud, Y.; Hoffman, M.; Lefrapper, L.; Lin, F.‐C.; Genty, A.; Chatard, B.; Marin, S.; Négrier, C.; Monroe, D. M.

Favourites:
ADD

Free Content The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study
pp. 1053-1058(6)
Authors: Poli, D.; Antonucci, E.; Testa, S.; Cosmi, B.; Palareti, G.; Ageno, W.; FCSA (Italian Federation of Anticoagulation Clinics)jth12239-cr-0007

Favourites:
ADD

Free Content Drospirenone and non‐fatal venous thromboembolism: is there a risk difference by dosage of ethinyl‐estradiol?
pp. 1059-1068(10)
Authors: Bird, S. T.; Delaney, J. A. C.; Etminan, M.; Brophy, J. M.; Hartzema, A. G.

Favourites:
ADD

Free Content Endogenous t‐PA‐antigen is an independent predictor of adverse cardiovascular events and all‐cause death in patients with atrial fibrillation
pp. 1069-1077(9)
Authors: Freynhofer, M. K.; Draxler, D. F.; Gruber, S. C.; Bruno, V.; Höchtl, T.; Fellner, B.; Jakl‐Kotauschek, G.; Wojta, J.; Pabinger‐Fasching, I.; Huber, K.; Ay, C.

Favourites:
ADD

Free Content Statin therapy and levels of hemostatic factors in a healthy population: the Multi‐Ethnic Study of Atherosclerosis
pp. 1078-1084(7)
Authors: Adams, N. B.; Lutsey, P. L.; Folsom, A. R.; Herrington, D. H.; Sibley, C. T.; Zakai, N. A.; Ades, S.; Burke, G. L.; Cushman, M.

Favourites:
ADD

Free Content Effect of low‐dose supplements of menaquinone‐7 (vitamin K2) on the stability of oral anticoagulant treatment: dose–response relationship in healthy volunteers
pp. 1085-1092(8)
Authors: Theuwissen, E.; Teunissen, K. J.; Spronk, H. M. H.; Hamulyák, K.; Ten Cate, H.; Shearer, M. J.; Vermeer, C.; Schurgers, L. J.

Favourites:
ADD

Free Content β2‐Glycoprotein I binds thrombin and selectively inhibits the enzyme procoagulant functions
pp. 1093-1102(10)
Authors: Pozzi, N.; Acquasaliente, L.; Frasson, R.; Cristiani, A.; Moro, S.; Banzato, A.; Pengo, V.; Scaglione, G. L.; Arcovito, A.; Cristofaro, R.; Filippis, V.

Favourites:
ADD

Free Content Characterization of large deletions in the F8 gene using multiple competitive amplification and the genome walking technique
pp. 1103-1110(8)
Authors: You, G. L.; Ding, Q. L.; Lu, Y. L.; Dai, J.; Xi, X. D.; Wang, X. F.; Wang, H. L.

Favourites:
ADD

Free Content In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban
pp. 1111-1118(8)
Authors: Dinkelaar, J.; Molenaar, P. J.; Ninivaggi, M.; Laat, B.; Brinkman, H. J. M.; Leyte, A.

Favourites:
ADD

Free Content Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
pp. 1119-1127(9)
Authors: Manco‐Johnson, M. J.; Kempton, C. L.; Reding, M. T.; Lissitchkov, T.; Goranov, S.; Gercheva, L.; Rusen, L.; Ghinea, M.; Uscatescu, V.; Rescia, V.; Hong, W.

Favourites:
ADD

Free Content A chemically‐modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity
pp. 1128-1136(9)
Authors: Fazavana, J.; Bianchini, E. P.; Saller, F.; Smadja, C.; Picard, V.; Taverna, M.; Borgel, D.

Favourites:
ADD

Free Content Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein
pp. 1137-1145(9)
Authors: Waters, E. K.; Genga, R. M.; Thomson, H. A.; Kurz, J. C.; Schaub, R. G.; Scheiflinger, F.; McGinness, K. E.

Favourites:
ADD

Free Content FcγRIIa proteolysis as a diagnostic biomarker for heparin‐induced thrombocytopenia
pp. 1146-1153(8)
Authors: Nazi, I.; Arnold, D. M.; Smith, J. W.; Horsewood, P.; Moore, J. C.; Warkentin, T. E.; Crowther, M. A.; Kelton, J. G.

Favourites:
ADD

Free Content Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition
pp. 1154-1162(9)
Authors: Guenther, F.; Herr, N.; Mauler, M.; Witsch, T.; Roming, F.; Hein, L.; Boeynaems, J.‐M.; Robaye, B.; Idzko, M.; Bode, C.; Zur Muhlen, C.; Duerschmied, D.

Favourites:
ADD

Free Content C560Rβ3 caused platelet integrin αII bβ3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality
pp. 1163-1171(9)
Authors: Fang, J.; Nurden, P.; North, P.; Nurden, A. T.; Du, L. M.; Valentin, N.; Wilcox, D. A.

Favourites:
ADD

Free Content Acute‐phase concentrations of soluble fibrinogen inhibit neutrophil adhesion under flow conditions in vitro through interactions with ICAM‐1 and MAC‐1 (CD11b/CD18)
pp. 1172-1182(11)
Authors: Pillay, J.; Kamp, V. M.; Pennings, M.; Oudijk, E.‐J.; Leenen, L. P.; Ulfman, L. H.; Koenderman, L.

Favourites:
ADD

Free Content Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
pp. 1183-1189(7)
Authors: Cattaneo, M.; Cerletti, C.; Harrison, P.; Hayward, C. P. M.; Kenny, D.; Nugent, D.; Nurden, P.; Rao, A. K.; Schmaier, A. H.; Watson, S. P.; Lussana, F.; Pugliano, M. T.; Michelson, A. D.

Favourites:
ADD

Free Content Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
pp. 1190-1193(4)
Authors: Lacroix, R.; Judicone, C.; Mooberry, M.; Boucekine, M.; Key, N. S.; Dignat‐George, F.; the ISTH SSC Workshopjth12207-cr-0007

Favourites:
ADD

Free Content Coagulation‐related gene expression profile in glioblastoma is defined by molecular disease subtype
pp. 1197-1200(4)
Authors: Magnus, N.; Gerges, N.; Jabado, N.; Rak, J.

Favourites:
ADD

Free Content Evaluation of the effects of single‐nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses
pp. 1200-1203(4)
Authors: Schie, R. M. F.; Aoussar, A.; Meer, F. J. M.; Boer, A.; Maitland‐van der Zee, A. H.

Favourites:
ADD

Free Content Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal
pp. 1203-1205(3)
Authors: Poller, L.; Jespersen, J.; Ibrahim, S.; Pattison, A.; the European Action on Anticoagulation (EAA)jth12164-cr-0005

Favourites:
ADD

Free Content Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a reply to a rebuttal
pp. 1205-1206(2)
Authors: Pengo, V.; Marongiu, F.; Members of the Steering Committee of the Italian Federation of Thrombosis Centers (FCSA)jth12210-cr-0003

Favourites:
ADD

Free Content Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients: a rebuttal
pp. 1207-1208(2)
Authors: Fabbian, F.; Dentali, F.; Ageno, W.; Manfredini, R.

Favourites:
ADD

Free Content Corrigendum
pp. 1209-1209(1)

Favourites:
ADD

Free Content Join ISTH
pp. 1210-1211(2)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more